As IFN-γ producing CD4+ T cells have been implicated in protective immunity to both liver and blood stage infections, an efficacious vaccine for infants and young children aims to not only induce CD4+ T cell help but ‘boost’ the level of TID antibody production above that which occurs during a natural malaria infection to levels observed for adults. The gene discussed is IFNG; the disease is infection.